Literature DB >> 19685025

Late effects surveillance system after childhood cancer in Germany, austria and parts of Switzerland--update 2009.

Joanna Peeters1, Johannes Meitert, Marios Paulides, Jörn D Beck, Thorsten Langer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19685025     DOI： 10.1007/s00066-009-1004-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  10 in total

1.  [Position paper of the Society of Pediatric Oncology and Hematology (GPOH) on (long-term) surveillance, (long-term) follow-up and late effect evaluation in pediatric oncology patients].

Authors:  G Calaminus; P Kaatsch
Journal:  Klin Padiatr       Date:  2007 May-Jun       Impact factor: 1.349

2.  German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results.

Authors:  Tobias Bölling; Andreas Schuck; Hildegard Pape; Christian Rübe; Frank-Michael Meyer; Carmen Martini; Beate Timmermann; Branka Asadpour; Rolf-Dieter Kortmann; Jörn D Beck; Thorsten Langer; Marios Paulides; Normann Willich
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

3.  NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity.

Authors:  Leszek Wojnowski; Bettina Kulle; Markus Schirmer; Gregor Schlüter; Albrecht Schmidt; Albert Rosenberger; Stefan Vonhof; Heike Bickeböller; Mohammad Reza Toliat; Eun-Kyung Suk; Mladen Tzvetkov; Anke Kruger; Silvia Seifert; Marita Kloess; Heidi Hahn; Markus Loeffler; Peter Nürnberg; Michael Pfreundschuh; Lorenz Trümper; Jürgen Brockmöller; Gerd Hasenfuss
Journal:  Circulation       Date:  2005-12-05       Impact factor: 29.690

Review 4.  Late effects of thoracic irradiation in children.

Authors:  Tobias Bölling; Stefan Könemann; Iris Ernst; Normann Willich
Journal:  Strahlenther Onkol       Date:  2008-06       Impact factor: 3.621

5.  Having children after surviving cancer in childhood or adolescence - results of a Berlin survey.

Authors:  S Reinmuth; A-K Liebeskind; L Wickmann; A Bockelbrink; T Keil; G Henze; A Borgmann
Journal:  Klin Padiatr       Date:  2008 May-Jun       Impact factor: 1.349

6.  [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].

Authors:  Christian Ullmann; Jörn-Dirk Beck; Wolfgang Holter; Sabrina Petsch; Jürgen Dunst; Rolf Sauer; Gerhard G Grabenbauer
Journal:  Strahlenther Onkol       Date:  2008-03       Impact factor: 3.621

7.  Health-related quality of life (HRQL) in all-patients treated with chemotherapy only: a report from the late effects surveillance system in Germany.

Authors:  J Peeters; J Meitert; M Paulides; A Wiener; J D Beck; G Calaminus; T Langer
Journal:  Klin Padiatr       Date:  2009-05-12       Impact factor: 1.349

8.  The cohort of long-term survivors at the German childhood cancer registry.

Authors:  D Debling; C Spix; M Blettner; J Michaelis; P Kaatsch
Journal:  Klin Padiatr       Date:  2008-10-23       Impact factor: 1.349

9.  Quality of survival in children and adolescents after treatment for childhood cancer: the influence of reported late effects on health related quality of life.

Authors:  G Calaminus; S Weinspach; C Teske; U Göbel
Journal:  Klin Padiatr       Date:  2007 May-Jun       Impact factor: 1.349

Review 10.  Second tumors after oncologic treatment.

Authors:  Wolfgang Dörr; Thomas Herrmann
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621
  10 in total
  4 in total

1.  Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?

Authors:  B Knäusl; C Lütgendorf-Caucig; J Hopfgartner; K Dieckmann; L Kurch; T Pelz; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

2.  Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.

Authors:  Frank Heinzelmann; Daniela Thorwarth; Ulf Lamprecht; Theodor W Kaulich; Jörg Fuchs; Guido Seitz; Martin Ebinger; Rupert Handgretinger; Michael Bamberg; Martin Weinmann
Journal:  Strahlenther Onkol       Date:  2011-10-29       Impact factor: 3.621

Review 3.  Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literature.

Authors:  Klaus Müller; Isabella Zwiener; Helmut Welker; Eberhard Maass; Rudolf Bongartz; Frank Berthold; Torsten Pietsch; Monika Warmuth-Metz; André von Bueren; Stefan Rutkowski
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

Review 4.  [Surveillance in patients with bone sarcomas. When, how, and for how long?].

Authors:  H R Dürr; P-U Tunn; Y Bakhshai
Journal:  Unfallchirurg       Date:  2014-06       Impact factor: 1.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.